Willett Robert 4
4 · COGNEX CORP · Filed Feb 20, 2025
Insider Transaction Report
Form 4
COGNEX CORPCGNX
Willett Robert
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-02-18+193,201→ 193,201 totalExercise: $33.04From: 2026-02-18Exp: 2035-02-18→ Common Stock (193,201 underlying) - Award
Restricted Stock Unit
2025-02-18+70,824→ 70,824 totalExercise: $0.00From: 2026-02-18Exp: 2028-02-18→ Common Stock (70,824 underlying)
Holdings
- 15,804(indirect: By Trust)
Common Stock
- 180,000
Non-Qualified Stock Option (right to buy)
Exercise: $38.39From: 2018-02-21Exp: 2027-02-21→ Common Stock (180,000 underlying) - 298,150
Non-Qualified Stock Option (right to buy)
Exercise: $39.44From: 2025-02-20Exp: 2034-02-20→ Common Stock (298,150 underlying) - 233,484
Non-Qualified Stock Option (right to buy)
Exercise: $47.21From: 2024-02-21Exp: 2033-02-21→ Common Stock (233,484 underlying) - 180,000
Non-Qualified Stock Option (right to buy)
Exercise: $50.94From: 2021-02-18Exp: 2030-02-18→ Common Stock (180,000 underlying) - 180,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (180,000 underlying) - 90,000
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (90,000 underlying) - 185,254
Non-Qualified Stock Option (right to buy)
Exercise: $64.43From: 2023-02-22Exp: 2032-02-22→ Common Stock (185,254 underlying) - 123,521
Non-Qualified Stock Option (right to buy)
Exercise: $90.50From: 2022-02-16Exp: 2031-02-16→ Common Stock (123,521 underlying)
Footnotes (4)
- [F1]The reporting person is a trustee and beneficiary of Willett Parkhill Investment Trust dated August 2, 2010. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- [F2]The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
- [F3]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- [F4]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively.